Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents

Journal: Nature Medicine

Published: 2020-06-29

DOI: 10.1038/s41591-020-0910-8

Affiliations: 10

Authors: 21

Go to article
Institutions Share
Argenx SE, Belgium 0.40
University of Bern (UniBE), Switzerland 0.22
Bern University Hospital, Switzerland 0.18
University Hospital Zurich (UHZ), Switzerland 0.10
Swiss Institute of Bioinformatics (SIB), Switzerland 0.07
Fung Consulting Healthcare Life Sciences, Germany 0.02